New Jersey Bariatric Center
sign in
menu
November 14, 2025
Are Wegovy® Pills and other Oral Weight Loss Medications Worth the Wait? What the Clinical Data Shows

Updated on December 23, 2025 to include the FDA approval of the Wegovy®pill by Novo Nordisk. With FDA-approval of the Wegovy® pill by Novo Nordisk in December 2025, the first oral versions ofGLP-1 weight loss medications are scheduled to reach the market in January 2026. Eli Lilly’s weight loss pill, Orforglipron, is still awaiting FDA-approval […]

Read More
May 27, 2025
Wegovy®, Saxenda® or Qsymia®: Which Prescription Weight Loss Medication is Best for Me?

Wegovy®, Saxenda®, and Qsymia® are FDA-Approved Prescription Weight Loss Medications Available to Weight Loss Patients in New Jersey Who Qualify With so many choices how do you know which medication is best for you? Here's some points to help you decide.  Do I Qualify for Weight Loss Medications? First, determine if you meet the criteria […]

Read More
chevron-down linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram